Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.

Aging - 12 Jan 2020

He Yuting, Dang Qin, Li Jie, Zhang Qiyao, Yu Xiao, Xue Miaomiao, Guo Wenzhi

Abstract excerpt

Hepatocellular carcinoma (HCC) is a common type of malignant tumor with an extremely poor prognosis. Because many HCC patients are diagnosed with advanced disease, surgical treatment is typically not possible, and other currently available treatments are often ineffective. Immunotherapy is being explored as a new treatment method for a variety of cancers, including HCC. However, there have been no systematic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Hepatocellular
Share to Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Kaplan-Meier Estimate

Share to Liver Neoplasms

Share to MicroRNAs

Share to Proportional Hazards Models

Source

Open in PubMed Open full text

Identifiers

PMID: 31929113
DOI: 10.18632/aging.102669
PMCID: PMC6977696

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set.PMID 31929113Read ↗

An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Hepatocellular CarcinomaSemantic proximity Read ↗

Identification and validation of an immune-related prognostic signature for hepatocellular carcinomaSemantic proximity Read ↗

Development and validation of a novel immune-related prognostic model in hepatocellular carcinomaSemantic proximity Read ↗

Establishment of a Prognostic Model Using Immune-Related Genes in Patients With Hepatocellular CarcinomaSemantic proximity Read ↗

Prognostic Value and Regulatory Network of Immune-Related Genes in Hepatocellular CarcinomaSemantic proximity Read ↗

A Prognostic Gene Signature for Hepatocellular CarcinomaSemantic proximity Read ↗

Development of a Predictive Immune-Related Gene Signature Associated With Hepatocellular Carcinoma Patient Prognosis.Semantic proximity Read ↗

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltrationSemantic proximity Read ↗

Comprehensive analysis of immune prognostic‐related genes in the tumor microenvironment of hepatocellular carcinomaSemantic proximity Read ↗

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinomaSemantic proximity Read ↗

Identification of Biomarkers of Hepatocellular Carcinoma Gene Prognosis Based on Immune-Related lncRNA Signature of Transcriptome DataSemantic proximity Read ↗

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.